Vaxil Signs Letter of Intent to Acquire a 100% Interest in Short Wave Pharma Inc.
October 14, 2021 10:52 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Oct. 14, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative biotech...
Vaxil Announces Progress on Research and Development Activities
October 12, 2021 09:07 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Oct. 12, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces Progress on Research and Development Activities
September 29, 2021 07:50 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Sept. 29, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces Changes to Senior Management and Provides Updates on Current Research and Development Work
August 04, 2021 07:50 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Aug. 04, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Provides Research and Development Update
May 31, 2021 07:50 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, May 31, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces CEO Resignation
May 05, 2021 17:00 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, May 05, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces 2021 Reseach and Development Strategy and Progress
March 11, 2021 15:51 ET
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, March 11, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
Vaxil Provides Strategy Update From Conclusion of COVID-19 Challenge Study
February 17, 2021 13:25 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, ISRAEL, Feb. 17, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Appoints a Special Advisor to the Board of Directors
February 01, 2021 08:32 ET
|
Vaxil Bio Ltd.
FURTHER UPDATE ON USAMRIID CHALLENGE AND ADDITIONAL EUROPEAN PATENT GRANTED FOR VAXIL’S ANTICANCER ANTIBODY PLATFORM Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Feb. ...
Vaxil Provides Update on USAMRIID, Oral Experiment and Other General Business Matters
January 27, 2021 07:50 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Jan. 27, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...